JP2012526094A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526094A5
JP2012526094A5 JP2012509111A JP2012509111A JP2012526094A5 JP 2012526094 A5 JP2012526094 A5 JP 2012526094A5 JP 2012509111 A JP2012509111 A JP 2012509111A JP 2012509111 A JP2012509111 A JP 2012509111A JP 2012526094 A5 JP2012526094 A5 JP 2012526094A5
Authority
JP
Japan
Prior art keywords
group
compound according
lipid compound
lipid
icosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012509111A
Other languages
English (en)
Japanese (ja)
Other versions
JP5843755B2 (ja
JP2012526094A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/001251 external-priority patent/WO2010128401A1/en
Publication of JP2012526094A publication Critical patent/JP2012526094A/ja
Publication of JP2012526094A5 publication Critical patent/JP2012526094A5/ja
Application granted granted Critical
Publication of JP5843755B2 publication Critical patent/JP5843755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012509111A 2009-05-08 2010-05-07 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸 Active JP5843755B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17650309P 2009-05-08 2009-05-08
US61/176,503 2009-05-08
PCT/IB2010/001251 WO2010128401A1 (en) 2009-05-08 2010-05-07 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015151385A Division JP2016026146A (ja) 2009-05-08 2015-07-31 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸

Publications (3)

Publication Number Publication Date
JP2012526094A JP2012526094A (ja) 2012-10-25
JP2012526094A5 true JP2012526094A5 (enExample) 2013-06-20
JP5843755B2 JP5843755B2 (ja) 2016-01-13

Family

ID=43050039

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012509111A Active JP5843755B2 (ja) 2009-05-08 2010-05-07 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
JP2015151385A Pending JP2016026146A (ja) 2009-05-08 2015-07-31 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015151385A Pending JP2016026146A (ja) 2009-05-08 2015-07-31 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸

Country Status (29)

Country Link
US (2) US8735436B2 (enExample)
EP (1) EP2427415B1 (enExample)
JP (2) JP5843755B2 (enExample)
KR (1) KR101783817B1 (enExample)
CN (1) CN102459142B (enExample)
AR (2) AR078507A1 (enExample)
AU (1) AU2010244136B2 (enExample)
BR (1) BRPI1015120B8 (enExample)
CA (1) CA2760877C (enExample)
CL (1) CL2011002745A1 (enExample)
CO (1) CO6430454A2 (enExample)
DK (1) DK2427415T3 (enExample)
EA (1) EA021177B1 (enExample)
ES (1) ES2726765T3 (enExample)
HR (1) HRP20190732T1 (enExample)
IL (1) IL216171A (enExample)
MA (1) MA33341B1 (enExample)
MX (2) MX366137B (enExample)
MY (1) MY165292A (enExample)
NZ (2) NZ618734A (enExample)
PH (1) PH12015500930B1 (enExample)
PL (1) PL2427415T3 (enExample)
PT (1) PT2427415T (enExample)
SG (1) SG175401A1 (enExample)
TR (1) TR201905768T4 (enExample)
TW (1) TWI558395B (enExample)
UA (1) UA109528C2 (enExample)
WO (1) WO2010128401A1 (enExample)
ZA (2) ZA201108163B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2733353T3 (es) 2007-11-09 2019-11-28 Basf As Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento
JP5395160B2 (ja) 2008-03-26 2014-01-22 オラムド エルティーディー． タンパク質の経口投与方法及び組成物
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
PT2427415T (pt) * 2009-05-08 2019-05-31 Basf As Ácidos gordos polinsaturados para o tratamento de doenças relacionadas com as áreas cardiovascular, metabólica e de doença inflamatória
EP2493328A1 (en) 2009-10-30 2012-09-05 Tharos Ltd. Solvent-free process for obtaining phospholipids and neutral enriched krill oils
GB201014633D0 (en) 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
EP2635270B1 (en) * 2010-11-05 2016-12-21 Pronova BioPharma Norge AS Methods of treatment using lipid compounds
WO2014083528A2 (en) * 2012-12-02 2014-06-05 Mahesh Kandula Compositions and methods for the treatment of cardiovascular diseases and lipid disorders
EP2941267B1 (en) 2013-01-03 2022-11-16 Oramed Ltd. Compositions for use in treating nafld
KR102213143B1 (ko) * 2013-02-28 2021-02-08 바스프 에이에스 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법
US9365482B2 (en) * 2013-02-28 2016-06-14 Pronova Biopharma Norge As Methods of preparing fatty acid derivatives
GB201409363D0 (en) 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
JP7341916B2 (ja) * 2015-04-01 2023-09-11 ビーエーエスエフ エーエス アポｃ３を低下させるためのチアオキソ化合物の使用
WO2016156912A1 (en) * 2015-04-01 2016-10-06 Pronova Biopharma Norge As Use of thia oxo compounds for lowering apo c3
BR112017023164A2 (en) * 2015-04-28 2018-07-24 Pronova Biopharma Norge As and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof
GB201521085D0 (en) * 2015-11-30 2016-01-13 Biozep As Use
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
WO2018055062A1 (en) 2016-09-21 2018-03-29 Avexxin As Pharmaceutical composition
HUE063275T2 (hu) 2017-05-16 2024-01-28 Ability Pharmaceuticals S A Gyógyszerészeti kombináció rákbetegség kezelésére
JP7312184B2 (ja) * 2017-10-23 2023-07-20 エピトラッカー インコーポレイテッド 脂肪酸アナログおよび代謝症候群に関連する症状の処置におけるそれらの使用
IL275002B2 (en) 2017-12-06 2024-04-01 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
JP7492459B2 (ja) * 2018-05-16 2024-05-29 エピトラッカー インコーポレイテッド 加齢に関連する状態の診断及び治療のための組成物及び方法
KR20250150676A (ko) 2018-05-23 2025-10-20 노스씨 테라퓨틱스 비.브이. 당뇨 제어 및 염증성장질환 치료의 향상을 위한 구조적으로 변형된 지방산
EP3796976A4 (en) 2018-05-23 2022-03-30 Epitracker, Inc. COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO LONGEVITY AND QUALITY OF AGING
US12473249B2 (en) * 2018-10-11 2025-11-18 Basf As Aromatic compounds and pharmaceutical uses thereof
EP3908374A4 (en) 2019-01-09 2022-12-28 Epitracker, Inc. COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
WO2020180814A1 (en) 2019-03-04 2020-09-10 Epitracker, Inc. Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain
BR112022001488A2 (pt) 2019-07-29 2022-04-19 Heparegenix Gmbh Inibidores de proteínas quinases de pirazolo-piridina substituída com heteroarila para promover regeneração do fígado ou redução ou prevenção de morte de hepatócitos
CA3164361A1 (en) 2020-01-15 2021-07-22 Heparegenix Gmbh 3-benzoyl-1h-pyrrolo[2,3-b]pyridine derivatives as mkk4 inhibitors for treating liver diseases
MX2023007347A (es) 2020-12-22 2023-08-16 Northsea Therapeutics B V Terapias de combinacion que comprenden acidos grasos estructuralmente mejorados que contienen oxigeno para el tratamiento de la esteatohepatitis no alcoholica.
EP4426130A1 (en) 2021-11-03 2024-09-11 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909554A (en) 1956-07-23 1959-10-20 Monsanto Chemicals Process for the manufacture of (alkylmercapto) alkyl sulfates
GB1038723A (enExample) 1962-03-26
US4040781A (en) 1974-06-06 1977-08-09 Lever Brothers Company Novel 2-(alkylsulfinyl)ethyl sulfates and compositions employing same
US4032564A (en) 1974-09-09 1977-06-28 Zoecon Corporation Esters of cyclopropylalkanols
GB1523276A (en) 1974-09-20 1978-08-31 Lafon Labor Sulphur-containing amino compounds
US4009211A (en) 1975-07-29 1977-02-22 Gulf Research & Development Company Beta,beta-dialkylethylmercaptoethoxylate as new compounds
US4209410A (en) 1976-04-28 1980-06-24 Phillips Petroleum Company Lubricants
DE2861974D1 (en) 1977-11-11 1982-09-16 Ciba Geigy Ag Pyridine dicarboxylic acid derivatives, their mixtures with metallic stabilisers and their use in stabilising chlorine-containing thermoplasts
JPS5570841A (en) 1978-11-24 1980-05-28 Konishiroku Photo Ind Co Ltd Forming method of dye image
US4368190A (en) 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
EP0050327B1 (de) 1980-10-21 1984-06-20 Roche Diagnostics GmbH Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4411808A (en) 1982-08-04 1983-10-25 Exxon Research & Engineering Co. Multifunctional additive for power transmission shift fluids
JPS6176438A (ja) * 1984-09-20 1986-04-18 Canon Inc 乳酸誘導体
US4775223A (en) 1984-09-20 1988-10-04 Canon Kabushiki Kaisha Lactic acid derivative, liquid crystal composition containing same and liquid crystal device
CA2010000A1 (en) 1989-04-07 1990-10-07 Paul B. Merkel Photographic recording material containing a cyan dye-forming coupler
JPH0451149A (ja) 1990-06-19 1992-02-19 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
FR2663928B1 (fr) 1990-06-27 1994-04-08 Norsolor Nouveaux composes acryliques soufres, un procede pour leur preparation et leur application a la synthese de nouveaux polymeres.
EP0487809A1 (en) 1990-11-28 1992-06-03 Monsanto Europe S.A./N.V. Rubber compositions having improved processability and improved rubber-vulcanisate properties
JPH0543529A (ja) 1991-08-10 1993-02-23 Taisho Pharmaceut Co Ltd アルカンアミドアンモニウム化合物
JP2793458B2 (ja) 1992-03-19 1998-09-03 三井化学株式会社 コネクター用ポリアミド系樹脂組成物およびコネクター
JP2755279B2 (ja) 1992-03-19 1998-05-20 三井化学株式会社 熱可塑性樹脂組成物およびその成形体
ATE226437T1 (de) 1993-06-10 2002-11-15 Univ Wake Forest (phospho)lipide zum bekämpfen einer hepatitis b- infektion
JP3110918B2 (ja) 1993-06-18 2000-11-20 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
US5523430A (en) * 1994-04-14 1996-06-04 Bristol-Myers Squibb Company Protein farnesyl transferase inhibitors
GB2290789B (en) 1994-07-01 1998-09-16 Ciba Geigy Ag Titanium and zirconium complexes of carboxylic acids as corrosion inhibitors
CN1088058C (zh) 1994-10-13 2002-07-24 肽技术有限公司 经修饰的多不饱和脂肪酸
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FR2741619B1 (fr) 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
US6262119B1 (en) * 1996-04-12 2001-07-17 Peptide Technology Limited Methods of treating immunopathologies using polyunsaturated fatty acids
US6060515A (en) 1997-01-24 2000-05-09 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
WO1998032444A1 (en) * 1997-01-24 1998-07-30 The Regents Of The University Of California USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION
AU4806497A (en) * 1997-10-01 1999-04-23 Procter & Gamble Company, The Glyoxylic compound comprising one or more active ingredient
JPH11180929A (ja) 1997-12-19 1999-07-06 Asahi Glass Co Ltd エステル誘導体
WO1999058120A1 (en) 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
FR2786187B1 (fr) 1998-11-19 2001-11-09 Univ Paris Curie Composes du type 2-acylamino-2-deoxy-glucono-1,5-lactone, procede d'obtention, compositions les comportant et utilisations
FR2792312B1 (fr) 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
CA2375822A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Substituted biaryl ether compounds
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
WO2001090087A1 (en) * 2000-05-26 2001-11-29 Nippon Shinyaku Co., Ltd. Heterocyclic compounds
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
US20030147814A1 (en) 2001-12-21 2003-08-07 3M Innovative Properties Company Medicinal aerosol formulations comprising ion pair complexes
GB2383355A (en) 2001-12-22 2003-06-25 Schlumberger Holdings An aqueous viscoelastic fluid containing hydrophobically modified polymer and viscoelastic surfactant
CN100392108C (zh) 2002-01-31 2008-06-04 Tfl皮革技术有限责任公司 组合物及其用途
US7273852B2 (en) 2002-06-13 2007-09-25 The Research Foundation Of The City University Of New York Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
FR2845991B1 (fr) 2002-10-16 2005-02-04 Pf Medicament Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
JPWO2004076404A1 (ja) 2003-02-28 2006-06-01 株式会社カネカ ２位に置換基を有する光学活性化合物の製造法
DE10326303A1 (de) 2003-06-11 2004-12-30 Celares Gmbh Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung
US20090215895A1 (en) * 2004-01-30 2009-08-27 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
JP4563114B2 (ja) 2004-08-30 2010-10-13 出光興産株式会社 潤滑剤用添加剤
WO2006109491A1 (ja) 2005-03-31 2006-10-19 Yamaguchi University 波力エネルギー変換装置
JP5337479B2 (ja) 2005-05-04 2013-11-06 プロノヴァ・バイオファーマ・ノルゲ・アーエス 新規化合物
CN101213281B (zh) * 2005-05-04 2013-03-13 普罗诺瓦生物医药挪威公司 新的dha衍生物及其作为药物的用途
US20070167529A1 (en) 2006-01-17 2007-07-19 Walton Rebecca A Antimicrobial compositions for treating fabrics and surfaces
US8987329B2 (en) 2006-04-12 2015-03-24 Conopco, Inc. Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
EP1849449A1 (en) 2006-04-26 2007-10-31 3M Innovative Properties Company Filler containing composition and process for production and use thereof
US7763607B2 (en) 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
EA200802213A1 (ru) 2006-05-09 2009-10-30 Химекуэст Фармасьютикалз, Инк. Способы лечения заболеваний крови
JP5552313B2 (ja) * 2006-11-01 2014-07-16 プロノヴァ・バイオファーマ・ノルゲ・アーエス 脂質化合物
WO2008053340A1 (en) * 2006-11-03 2008-05-08 Pronova Biopharma Norge As A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent
CN101225064A (zh) 2007-01-19 2008-07-23 上海汇瑞生物科技有限公司 一种制备β-硫杂-α-烷基脂肪酸的新方法
DE102007017179A1 (de) * 2007-04-12 2008-10-23 Clariant International Ltd. Verfahren zur Herstellung von Alkylpolyglykolcarbonsäuren und Polyglykoldicarbonsäuren mittels Direktoxidation
US8604004B2 (en) * 2007-10-04 2013-12-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
EP2217558A1 (en) * 2007-10-31 2010-08-18 Pronova Biopharma Norge AS New dha derivatives and their use as medicaments
ES2733353T3 (es) 2007-11-09 2019-11-28 Basf As Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento
WO2009149496A1 (en) 2008-06-10 2009-12-17 Central Northern Adelaide Health Service Treatment of diabetes and complications thereof and related disorders
FR2933006B1 (fr) 2008-06-27 2010-08-20 Inst Francais Du Petrole Solution absorbante contenant un inhibiteur de degradation soufre a groupement carboxyle et methode pour limiter la degradation d'une solution absorbante
SG192488A1 (en) 2008-07-08 2013-08-30 Catabasis Pharmaceuticals Inc Fatty acid acetylated salicylates and their uses
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
PT2427415T (pt) * 2009-05-08 2019-05-31 Basf As Ácidos gordos polinsaturados para o tratamento de doenças relacionadas com as áreas cardiovascular, metabólica e de doença inflamatória
JP5802209B2 (ja) 2009-09-01 2015-10-28 カタバシス ファーマシューティカルズ，インコーポレイテッド 脂肪酸ナイアシン抱合体およびそれらの使用
WO2011089529A1 (en) 2010-01-20 2011-07-28 Pronova Biopharma Norge As Salicylate fatty acid derivatives
EP2635270B1 (en) 2010-11-05 2016-12-21 Pronova BioPharma Norge AS Methods of treatment using lipid compounds
WO2012115695A1 (en) 2011-02-25 2012-08-30 Catabasis Pharmaceuticals, Inc. Bis-fatty acid conjugates and their uses
WO2013016531A2 (en) 2011-07-26 2013-01-31 Purdue Research Foundation Compounds and methods for use in treating neoplasia and cancer

Similar Documents

Publication Publication Date Title
JP2012526094A5 (enExample)
HRP20190732T1 (hr) Polinezasićene masne kiseline za liječenje bolesti povezanih s kardiovaskularnim, metaboličkim i upalnim područjima bolesti
JP2011528350A5 (enExample)
TWI699354B (zh) 陽離子性脂質
JP2014505017A5 (enExample)
JP2004526745A5 (enExample)
JP2007509055A5 (enExample)
WO2011089529A4 (en) Salicylate fatty acid derivatives
JP6537980B2 (ja) 脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法
KR102265409B1 (ko) 지질 화합물을 이용한 치료방법
JP2009530398A5 (enExample)
JP5552314B2 (ja) 新規脂質化合物
JP2018515463A5 (enExample)
JP2011503057A5 (enExample)
IL318963A (en) Compositions comprising 15-hydroxy-eicosapentaenoic acid and methods of using them
JPWO2014129495A1 (ja) 眼疾患処置薬
JP2024511208A (ja) 治療薬のバイオアベイラビリティを改善した組成物
JP2018510206A5 (enExample)
RU2017137960A (ru) Применение тиаоксосоединений для уменьшения содержания аро сз
JP2006509038A5 (enExample)
JP6093015B2 (ja) 改良された流動性を有する医薬組成物、薬剤、並びに同一物を製造及び使用するための方法
JP2020536922A5 (enExample)
JP2013529686A5 (enExample)
US20150080471A1 (en) Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels
EP2607367A1 (en) Glycerol phenyl butyrate derivatives